- Abstract:
-
We examined the ability of selective CCK-A and CCK-B receptor antagonists to induce or modulate the locomotor stimulant effects of dopamine agonists in MPTP-treated squirrel monkeys. Administration of 1-100 micrograms/kg i.p. of either the selective CCK-A receptor antagonist devazepide (MK-329) or the CCK-B receptor antagonist L-365,260 alone failed to stimulate a locomotor response in parkinsonian monkeys. In contrast, treatment with L-365,260 caused a 50-60% potentiation of the locomotor st...
Expand abstract - Publication status:
- Published
- Journal:
- Clinical neuropharmacology
- Volume:
- 13
- Issue:
- 4
- Pages:
- 339-347
- Publication date:
- 1990-08-05
- DOI:
- EISSN:
-
1537-162X
- ISSN:
-
0362-5664
- URN:
-
uuid:da661001-7df2-42bf-9c51-8e88321eacd0
- Source identifiers:
-
21651
- Local pid:
- pubs:21651
- Copyright date:
- 1990
Journal article
Modulatory role for CCK-B antagonists in Parkinson's disease.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record